CORD-19:12fbecd4737a9af7b8fab5267094fdfa754f25fa / 13374-13710 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/12fbecd4737a9af7b8fab5267094fdfa754f25fa","sourcedb":"CORD-19","sourceid":"12fbecd4737a9af7b8fab5267094fdfa754f25fa","text":"With the discovery of the TLR family of receptors, many pathogen products with known immunepotentiating activity (adjuvants) have now been shown to activate innate immunity via TLRs, or through an increasing number of non-TLR PRRs, including CD14, Dectin1, TREM1 and 2, RNA-dependent kinase (PKR) and CD91 (REFS 4, (15) (16) (17) (18) .","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T72","span":{"begin":0,"end":336},"obj":"Sentence"}],"attributes":[{"subj":"T72","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T72","span":{"begin":0,"end":336},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T72","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#9c93ec","default":true},{"id":"CORD-19-Sentences","color":"#a4ec93"}]}]}}